News

Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.
Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...
The HHS wants to move oversight of the controversial drug discount program to the CMS, which has a more aggressive history ...
The S&P 500 rose by 0.52% on Friday to close at a record high of 6,173.07, marking returns of 3.44% for the week, as traders ...
Bankruptcies have left the casual dining scene to a group of best-of-breed companies, from Brinker International’s Chili’s to ...
Dubai: As the global economy faces mounting pressure — from trade wars to slowing demand — India is quietly charting a ...
Eli Lilly faces market headwinds, slowing growth, and rising competition. Discover why now might be the time for LLY ...
Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.
The Fidelity MSCI Health Care Index ETF (FHLC) was launched on 10/21/2013, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the ...
Review the current Eli Lilly and Co (LLY:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if LLY is the best investment for you.
Merck remains a top Big Pharma name with strong leadership, rising sales, and high margins, despite regulatory fears and ...
Plus: Why Krispy Kreme left McDonald's, Boeing's latest woes, the potential Shell-BP merger, Bumble's stumble, Nvidia's cloud ...